(MedPage Today) — CHICAGO — Research presented at the American Diabetes Association (ADA) annual meeting included a small phase I/II study on stem cell therapy for type 1 diabetes, a randomized trial of a once-monthly weight-loss injectable…
Source link : https://www.medpagetoday.com/meetingcoverage/ada/116226
Author :
Publish date : 2025-06-24 19:27:00
Copyright for syndicated content belongs to the linked Source.
